Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

Men with Kennedy disease have less chance of hair loss.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

Acne severity in women may not be linked to increased male hormone indicators like excess body hair, menstrual irregularities, or hair loss.

Most patients improved with oral contraceptives, but some needed additional treatment.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Laser hair removal is safe and effective for fair-skinned people with dark hair, and using eflornithine with laser treatments can improve results.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The perception of excessive hair growth in women as abnormal is more influenced by cultural norms than by medical reasons.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Androgens can cause hair growth in some areas but hair loss on the scalp.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Hirsutism causes significant psychological distress in women.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Androgens can both increase body hair and cause scalp hair loss.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Women with PCOS have worse physical health but similar mental health compared to those without PCOS.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.